A peer-reviewed journal that offers evidence-based clinical information and continuing education for dentists.

Inexpensive Antidepressant Medication May Reduce Severity of COVID-19


Research shows that fluvoxaminean, an inexpensive antidepressant medication, decreases the need for hospitalization among high-risk adults with COVID-19. The drug fights inflammation and is traditionally used to address depression and obsessive compulsive disorder. The Brazilian study included 1,500 subjects with COVID-19 who were at elevated risk for severe illness. Half of the subjects took fluvoxamine and the other half received a placebo. Of the participants who received the drug, 11% required hospitalization while 16% of those who received a placebo needed hospitalization. Click here to read more.

Leave A Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy